Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19
Alexander C Razavi1, Jonathan L Chang1, Aimee Sutherland1
1Tulane University, New Orleans, LA, USA.
Multisystem inflammatory syndrome (MIS) can affect adults over 21, even after mild COVID-19. Early treatment with immunoglobulin and steroids rapidly resolved symptoms in a young obese patient.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- COVID-19 (coronavirus disease 2019) has been linked to multisystem inflammatory syndrome (MIS).
- MIS typically affects pediatric populations, but adult cases are increasingly reported.
- Delayed onset MIS after mild or asymptomatic SARS-CoV-2 infection presents diagnostic challenges.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction
Pericarditis III: Medical Management
Pericarditis I: Introduction